As such, in addition to the inhibitory effect of FAK-I in the cytoplasmic FAK signaling, FAK-Is could prove beneficial in reducing tumor cell proliferation through forced FAK nuclear localization and shifting the balance of cell cycle regulators toward the inhibitory arm (i.e., increased p21/p27 and reduced cyclin D-CDK/46). The gene discussed is PTK2; the disease is neoplasm.